$2.06
17.93% yesterday
Nasdaq, Sep 24, 10:00 pm CET
ISIN
US0547544033
Symbol
AYTU

Aytu BioScience Inc Stock price

$2.06
-0.24 10.24% 1M
+0.83 67.48% 6M
+0.36 21.18% YTD
-0.37 15.23% 1Y
-1.64 44.32% 3Y
-237.94 99.14% 5Y
-4,559,997.94 100.00% 10Y
+1.74 543.75% 20Y
Nasdaq, Closing price Wed, Sep 24 2025
-0.45 17.93%
ISIN
US0547544033
Symbol
AYTU
Industry

Key metrics

Basic
Market capitalization
$12.7m
Enterprise Value
$16.0m
Net debt
$3.3m
Cash
$18.2m
Shares outstanding
6.2m
Valuation (TTM | estimate)
P/E
10.8 | 3.3
P/S
0.2 | 0.2
EV/Sales
0.2 | 0.2
EV/FCF
negative
P/B
0.4
Financial Health
Equity Ratio
23.5%
Return on Equity
-57.2%
ROCE
0.7%
ROIC
0.3%
Debt/Equity
0.6
Financials (TTM | estimate)
Revenue
$69.2m | $70.5m
EBITDA
$4.4m | $9.1m
EBIT
$368.0k | $-3.0m
Net Income
$1.6m | $3.8m
Free Cash Flow
$-5.7m
Growth (TTM | estimate)
Revenue
-26.2% | -12.9%
EBITDA
-37.1% | 290.8%
EBIT
-80.9% | -3.3%
Net Income
112.0% | 124.1%
Free Cash Flow
-165.5%
Margin (TTM | estimate)
Gross
68.6%
EBITDA
6.4% | 12.9%
EBIT
0.5%
Net
2.4% | 5.4%
Free Cash Flow
-8.3%
More
EPS
$0.2
FCF per Share
$-0.9
Short interest
6.6%
Employees
102
Rev per Employee
$790.0k
Show more

Is Aytu BioScience Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,008 stocks worldwide.

Aytu BioScience Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Aytu BioScience Inc forecast:

8x Buy
89%
1x Hold
11%

Analyst Opinions

9 Analysts have issued a Aytu BioScience Inc forecast:

Buy
89%
Hold
11%

Financial data from Aytu BioScience Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
69 69
26% 26%
100%
- Direct Costs 22 22
33% 33%
31%
47 47
22% 22%
69%
- Selling and Administrative Expenses 41 41
22% 22%
59%
- Research and Development Expense 2.15 2.15
3% 3%
3%
4.43 4.43
37% 37%
6%
- Depreciation and Amortization 4.07 4.07
20% 20%
6%
EBIT (Operating Income) EBIT 0.37 0.37
81% 81%
1%
Net Profit 1.64 1.64
112% 112%
2%

In millions USD.

Don't miss a Thing! We will send you all news about Aytu BioScience Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Aytu BioScience Inc Stock News

Neutral
Accesswire
about 14 hours ago
DENVER, CO / ACCESS Newswire / September 24, 2025 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients, today announced management will participate at the following investor conferences: MicroCap Rodeo Fall Conference Date: Thursda...
Neutral
Seeking Alpha
one day ago
Aytu BioPharma, Inc. (NASDAQ:AYTU ) Q4 2025 Earnings Call September 23, 2025 4:30 PM EDT Company Participants Joshua Disbrow - CEO & Director Ryan J. Selhorn - CFO, Corporate Secretary & Treasurer Conference Call Participants Robert Blum - Lytham Partners, LLC Thomas Flaten - Lake Street Capital Markets, LLC, Research Division Nazibur Rahman - Maxim Group LLC, Research Division Edward Woo - Asc...
Neutral
Accesswire
one day ago
Full year fiscal 2025 net revenue of $66.4 million Full year fiscal 2025 net loss of $13.6 million Full year fiscal 2025 adjusted EBITDA1 of $9.2 million $31.0 million cash balance at June 30, 2025 Exclusive agreement in June 2025 to commercialize EXXUA™ (gepirone) extended-release tablets ("EXXUA") is expected to serve as a major growth catalyst; the Company anticipates launching EXXUA in the ...
More Aytu BioScience Inc News

Company Profile

Aytu BioScience, Inc. is a specialty pharmaceutical company, which focuses on identifying, acquiring, and commercializing novel products. Its products include Natesto, Tuzistram, ZolpiMist and MiOXSYS. The company was founded on August 9, 2002 and is headquartered in Englewood, CO.

Head office United States
CEO Joshua Disbrow
Employees 102
Founded 2002
Website aytubio.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today